Walgreens Boots Alliance, Inc. (WBA) EV/EBIT Ratio: N/A
The EV/EBIT ratio for Walgreens Boots Alliance, Inc. (WBA) is N/A as of Saturday, June 13, 2026.
WBA EV/EBIT Ratio Chart
WBA Average EV/EBIT Ratio Chart
WBA EV/EBIT Ratio Metrics
EV/EBIT RATIO
N/A
EV/EBIT RATIO AVG TTM
25.59x
EV/EBIT RATIO AVG 3Y
34.39x
EV/EBIT RATIO AVG 5Y
25.01x
EV/EBIT RATIO AVG 10Y
21.04x
EV/EBIT RATIO AVG 15Y
17.01x
EV/EBIT RATIO AVG 20Y
17.03x
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
WBA Competitors' EV/EBIT Ratio
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Walgreens Boots Alliance, Inc. (WBA) | $10.37B | N/A | 25.59x | 34.39x | 25.01x |
| Baxter International Inc. (BAX) | $10.77B | N/A | 442.63x | 243.35x | 134.31x |
| Charles River Laboratories International, Inc. (CRL) | $9.03B | 25.40x | 62.63x | 38.51x | 35.13x |
| Tempus AI, Inc. (TEM) | $8.35B | N/A | -26.05x | -27.91x | -28.92x |
| Align Technology, Inc. (ALGN) | $12.52B | 19.57x | 19.29x | 26.44x | 31.41x |
| Bio-Rad Laboratories, Inc. (BIO) | $7.73B | 35.82x | 38.08x | 32.83x | 33.28x |
| The Cooper Companies, Inc. (COO) | $13.24B | 31.25x | 23.67x | 31.83x | 35.66x |
| Solventum Corporation (SOLV) | $13.66B | 8.70x | 20.82x | 17.36x | 17.36x |
| Hims & Hers Health, Inc. (HIMS) | $5.98B | 225.12x | 99.68x | 147.73x | 147.73x |
| Hologic, Inc. (HOLX) | $16.97B | 24.28x | 22.66x | 24.05x | 18.32x |
Walgreens Boots Alliance, Inc. EV/EBIT Ratio Formula & Definition
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Walgreens Boots Alliance, Inc. EV/EBIT Ratio FAQ
- What is the EV/EBIT ratio for Walgreens Boots Alliance, Inc. (WBA)?
- The EV/EBIT ratio for WBA stock is N/A.
- What is the TTM average EV/EBIT ratio for Walgreens Boots Alliance, Inc. (WBA)?
- The TTM average EV/EBIT ratio for WBA stock is 25.59x.
- What is the 3Y average EV/EBIT ratio for Walgreens Boots Alliance, Inc. (WBA)?
- The 3Y average EV/EBIT ratio for WBA stock is 34.39x.
- What is the 5Y average EV/EBIT ratio for Walgreens Boots Alliance, Inc. (WBA)?
- The 5Y average EV/EBIT ratio for WBA stock is 25.01x.
- What is the 10Y average EV/EBIT ratio for Walgreens Boots Alliance, Inc. (WBA)?
- The 10Y average EV/EBIT ratio for WBA stock is 21.04x.
- What is the 15Y average EV/EBIT ratio for Walgreens Boots Alliance, Inc. (WBA)?
- The 15Y average EV/EBIT ratio for WBA stock is 17.01x.
- What is the 20Y average EV/EBIT ratio for Walgreens Boots Alliance, Inc. (WBA)?
- The 20Y average EV/EBIT ratio for WBA stock is 17.03x.
Walgreens Boots Alliance, Inc. EV/EBIT Ratio History
| DATE | EV/EBIT RATIO |
|---|---|
| 2023-01-04 | 47.97x |
| 2023-01-03 | 47.78x |
| 2022-12-30 | 47.89x |
| 2022-12-29 | 47.95x |
| 2022-12-28 | 48.02x |
| 2022-12-27 | 48.48x |
| 2022-12-23 | 48.68x |
| 2022-12-22 | 48.56x |
| 2022-12-21 | 48.66x |
| 2022-12-20 | 49.24x |
| 2022-12-19 | 49.11x |
| 2022-12-16 | 48.94x |
| 2022-12-15 | 49.24x |
| 2022-12-14 | 49.92x |
| 2022-12-13 | 50.17x |
| 2022-12-12 | 50.19x |
| 2022-12-09 | 49.80x |
| 2022-12-08 | 50.09x |
| 2022-12-07 | 49.94x |
| 2022-12-06 | 49.90x |
| 2022-12-05 | 50.28x |
| 2022-12-02 | 50.45x |
| 2022-12-01 | 50.35x |
| 2022-11-30 | 50.47x |
| 2022-11-29 | 50.20x |
| 2022-11-28 | 50.04x |
| 2022-11-25 | 50.57x |
| 2022-11-23 | 50.63x |
| 2022-11-22 | 50.65x |
| 2022-11-21 | 49.90x |
| 2022-11-18 | 49.37x |
| 2022-11-17 | 49.61x |
| 2022-11-16 | 49.77x |
| 2022-11-15 | 49.94x |
| 2022-11-14 | 49.87x |
| 2022-11-11 | 50.32x |
| 2022-11-10 | 48.59x |
| 2022-11-09 | 47.59x |
| 2022-11-08 | 48.46x |
| 2022-11-07 | 48.65x |
| 2022-11-04 | 47.70x |
| 2022-11-03 | 46.88x |
| 2022-11-02 | 46.92x |
| 2022-11-01 | 47.20x |
| 2022-10-31 | 47.35x |
| 2022-10-28 | 47.40x |
| 2022-10-27 | 46.83x |
| 2022-10-26 | 46.73x |
| 2022-10-25 | 46.74x |
| 2022-10-24 | 46.22x |
| 2022-10-21 | 45.98x |
| 2022-10-20 | 45.39x |
| 2022-10-19 | 45.41x |
| 2022-10-18 | 45.23x |
| 2022-10-17 | 45.17x |
| 2022-10-14 | 45.32x |
| 2022-10-13 | 45.57x |
| 2022-10-12 | 20.08x |
| 2022-10-11 | 20.27x |
| 2022-10-10 | 20.05x |
| 2022-10-07 | 19.69x |
| 2022-10-06 | 20.17x |
| 2022-10-05 | 20.42x |
| 2022-10-04 | 20.48x |
| 2022-10-03 | 20.22x |
| 2022-09-30 | 19.93x |
| 2022-09-29 | 19.97x |
| 2022-09-28 | 20.43x |
| 2022-09-27 | 20.22x |
| 2022-09-26 | 20.29x |
| 2022-09-23 | 20.33x |
| 2022-09-22 | 20.46x |
| 2022-09-21 | 20.49x |
| 2022-09-20 | 20.65x |
| 2022-09-19 | 20.69x |
| 2022-09-16 | 20.73x |
| 2022-09-15 | 20.72x |
| 2022-09-14 | 20.87x |
| 2022-09-13 | 20.86x |
| 2022-09-12 | 21.38x |
| 2022-09-09 | 21.27x |
| 2022-09-08 | 21.20x |
| 2022-09-07 | 21.23x |
| 2022-09-06 | 21.02x |
| 2022-09-02 | 21.00x |
| 2022-09-01 | 21.00x |
| 2022-08-31 | 20.95x |
| 2022-08-30 | 20.98x |
| 2022-08-29 | 21.20x |
| 2022-08-26 | 21.21x |
| 2022-08-25 | 21.43x |
| 2022-08-24 | 21.42x |
| 2022-08-23 | 21.61x |
| 2022-08-22 | 21.57x |
| 2022-08-19 | 21.82x |
| 2022-08-18 | 21.83x |
| 2022-08-17 | 22.56x |
| 2022-08-16 | 22.88x |
| 2022-08-15 | 22.61x |
| 2022-08-12 | 22.48x |
| 2022-08-11 | 22.34x |
| 2022-08-10 | 22.29x |
| 2022-08-09 | 22.07x |
| 2022-08-08 | 22.17x |
| 2022-08-05 | 22.04x |
| 2022-08-04 | 22.03x |
| 2022-08-03 | 22.09x |
| 2022-08-02 | 22.05x |
| 2022-08-01 | 22.29x |
| 2022-07-29 | 22.21x |
| 2022-07-28 | 22.16x |
| 2022-07-27 | 22.10x |
| 2022-07-26 | 22.00x |
| 2022-07-25 | 21.97x |
| 2022-07-22 | 21.94x |
| 2022-07-21 | 21.89x |
| 2022-07-20 | 22.02x |
| 2022-07-19 | 21.93x |
| 2022-07-18 | 21.85x |
| 2022-07-15 | 21.77x |
| 2022-07-14 | 21.45x |
| 2022-07-13 | 21.55x |
| 2022-07-12 | 21.75x |
| 2022-07-11 | 21.60x |
| 2022-07-08 | 21.64x |
| 2022-07-07 | 21.82x |
| 2022-07-06 | 21.70x |
| 2022-07-05 | 21.90x |
| 2022-07-01 | 21.92x |
| 2022-06-30 | 21.73x |
| 2022-06-29 | 15.53x |
| 2022-06-28 | 15.55x |
| 2022-06-27 | 15.78x |
| 2022-06-24 | 15.68x |
| 2022-06-23 | 15.53x |
| 2022-06-22 | 15.45x |
| 2022-06-21 | 15.38x |
| 2022-06-17 | 15.24x |
| 2022-06-16 | 15.30x |
| 2022-06-15 | 15.50x |
| 2022-06-14 | 15.40x |
| 2022-06-13 | 15.42x |
| 2022-06-10 | 15.66x |
| 2022-06-09 | 15.69x |
| 2022-06-08 | 15.86x |
| 2022-06-07 | 15.93x |
| 2022-06-06 | 16.01x |
| 2022-06-03 | 15.96x |
| 2022-06-02 | 16.01x |
| 2022-06-01 | 15.98x |
| 2022-05-31 | 16.09x |
| 2022-05-27 | 16.07x |
| 2022-05-26 | 15.94x |
| 2022-05-25 | 15.83x |
| 2022-05-24 | 15.76x |
| 2022-05-23 | 15.77x |
| 2022-05-20 | 15.55x |
| 2022-05-19 | 15.48x |
| 2022-05-18 | 15.59x |
| 2022-05-17 | 16.30x |
| 2022-05-16 | 16.15x |
| 2022-05-13 | 16.04x |
| 2022-05-12 | 15.96x |
| 2022-05-11 | 16.00x |
| 2022-05-10 | 15.99x |
| 2022-05-09 | 16.09x |
| 2022-05-06 | 16.12x |
| 2022-05-05 | 16.08x |
| 2022-05-04 | 16.21x |
| 2022-05-03 | 15.92x |
| 2022-05-02 | 15.84x |
| 2022-04-29 | 15.82x |
| 2022-04-28 | 16.22x |
| 2022-04-27 | 16.16x |
| 2022-04-26 | 16.29x |
| 2022-04-25 | 16.38x |
| 2022-04-22 | 16.41x |
| 2022-04-21 | 16.65x |
| 2022-04-20 | 16.60x |
| 2022-04-19 | 16.42x |
| 2022-04-18 | 16.22x |
| 2022-04-14 | 16.27x |
| 2022-04-13 | 16.23x |
| 2022-04-12 | 16.16x |
| 2022-04-11 | 16.20x |
| 2022-04-08 | 16.39x |
| 2022-04-07 | 16.33x |
| 2022-04-06 | 16.18x |
| 2022-04-05 | 16.02x |
| 2022-04-04 | 16.01x |
| 2022-04-01 | 16.09x |
| 2022-03-31 | 16.27x |
| 2022-03-30 | 18.09x |
| 2022-03-29 | 18.17x |
| 2022-03-28 | 18.04x |
| 2022-03-25 | 18.02x |
| 2022-03-24 | 18.00x |
| 2022-03-23 | 17.94x |
| 2022-03-22 | 18.09x |
| 2022-03-21 | 18.08x |
| 2022-03-18 | 18.07x |
| 2022-03-17 | 18.10x |
| 2022-03-16 | 18.08x |
| 2022-03-15 | 18.24x |
| 2022-03-14 | 18.19x |
| 2022-03-11 | 18.09x |
| 2022-03-10 | 18.22x |
| 2022-03-09 | 18.23x |
| 2022-03-08 | 18.10x |
| 2022-03-07 | 18.00x |
| 2022-03-04 | 18.15x |
| 2022-03-03 | 17.94x |
| 2022-03-02 | 17.82x |
| 2022-03-01 | 17.58x |
| 2022-02-28 | 17.81x |
| 2022-02-25 | 17.83x |
| 2022-02-24 | 17.64x |
| 2022-02-23 | 17.68x |
| 2022-02-22 | 17.75x |
| 2022-02-18 | 17.92x |
| 2022-02-17 | 17.96x |
| 2022-02-16 | 18.18x |
| 2022-02-15 | 18.27x |
| 2022-02-14 | 18.07x |
| 2022-02-11 | 18.35x |
| 2022-02-10 | 18.46x |
| 2022-02-09 | 18.62x |
| 2022-02-08 | 18.58x |
| 2022-02-07 | 18.43x |
| 2022-02-04 | 18.33x |
| 2022-02-03 | 18.52x |
| 2022-02-02 | 18.71x |
| 2022-02-01 | 18.57x |
| 2022-01-31 | 18.57x |
| 2022-01-28 | 18.72x |
| 2022-01-27 | 18.62x |
| 2022-01-26 | 18.57x |
| 2022-01-25 | 18.83x |
| 2022-01-24 | 19.12x |
| 2022-01-21 | 19.15x |
| 2022-01-20 | 19.29x |
| 2022-01-19 | 19.36x |
| 2022-01-18 | 19.36x |
| 2022-01-14 | 19.52x |
| 2022-01-13 | 19.50x |
| 2022-01-12 | 19.44x |
| 2022-01-11 | 19.53x |
| 2022-01-10 | 19.40x |
| 2022-01-07 | 19.43x |
| 2022-01-06 | 19.13x |
| 2022-01-05 | 33.76x |
| 2022-01-04 | 33.57x |
| 2022-01-03 | 33.41x |
| 2021-12-31 | 33.08x |
| 2021-12-30 | 33.01x |
| 2021-12-29 | 33.11x |
| 2021-12-28 | 32.81x |
| 2021-12-27 | 32.55x |
| 2021-12-23 | 32.45x |
| 2021-12-22 | 32.43x |
Showing the most recent 260 of 4,914 data points. The chart above shows the full history.
Related Metrics
About Walgreens Boots Alliance, Inc.
Walgreens Boots Alliance, Inc., established in 1901 and based in Deerfield, Illinois, operates as a leading global retailer focused on pharmacy, health, and beauty products. Its business activities are organized into two primary divisions: the United States and International. In the United States, the company dispenses prescription drugs and offers a diverse selection of retail goods. This includes items for health, wellness, beauty, and personal care, alongside general merchandise and consumable products, all available through its extensive network of retail drugstores. The U.S. segment also provides specialized central pharmacy services and mail delivery options for prescriptions. As of August 31, 2021, this division managed 8,965 retail outlets under the Walgreens and Duane Reade banners, complemented by five specialty pharmacies. The International segment focuses on the sale of prescription medications, health and wellness items, beauty products, personal care essentials, and other consumer goods. These are sold through its pharmacy-centric health and beauty retail locations, optical practices, its online platform boots.com, and an integrated mobile application. Additionally, this segment engages in pharmaceutical wholesale and distribution operations within Germany. By August 31, 2021, the international portfolio included 4,031 retail stores operating under brands such as Boots, Benavides, and Ahumada, located across countries including the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile. It also oversaw 548 optical practices, with 160 of these operating as franchises.
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Timothy C. Wentworth